HEAL
Reasons to Consider HEAL
High Growth Potential
The healthcare sector is under strain due to rising demand from an aging population and workforce shortages. Technology presents a viable solution, with the size of the HealthTech market expected to exceed $1T by 2032.1
Healthcare Innovators
The Fund invests in companies at the intersection of healthcare and technology across four key sub-themes: healthcare analytics and software, smart medical devices, AI drug discovery, and tech-enabled consumer healthcare.
Timely Opportunity
A growing range of technologies are set to advance patient care, evidenced by increased AI device approvals, lower drug development costs and optimized administrative processes that are improving clinical workflows.
1Global X ETFs Forecasts, Mar 2025
Key Information
As of Jun 20 2025ETF Summary
The Global X HealthTech ETF (HEAL) invests in companies transforming healthcare through cutting-edge technology. The fund targets four sub-themes: AI-enabled drug discovery, smart medical devices, tech-enabled consumer healthcare, and healthcare analytics and software solutions. Companies in these areas harness advanced technologies to enhance patient care, streamline operations, and drive medical breakthroughs. By focusing on tech-driven innovation, HEAL seeks to provide exposure to firms shaping the future of healthcare.
ETF Objective
The Global X HealthTech ETF (HEAL) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Global X HealthTech Index.
Trading Details
As of Jun 18 2025Distributions
As of Jun 20 2025ETF Prices
As of Jun 20 2025| NAV | $10.61 | Daily Change | $0.04 | 0.38% |
| Market Price | $10.69 | Daily Change | $0.06 | 0.56% |
Performance History
| Fund NAV | Market Price | Index | |
|---|---|---|---|
| 1 Year | -1.26% | -0.63% | -0.61% |
| 3 Years | -13.44% | -13.38% | -13.05% |
| Since Inception | -9.74% | -9.70% | -9.29% |
| Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
|---|---|---|---|---|---|---|
| 6.06 | HIMS | HIMS & HERS HEALTH INC | BN46048 | 64.22 | 40,267 | 2,585,946.74 |
| 4.62 | TEM | TEMPUS AI INC | BSLSJJ0 | 68.31 | 28,814 | 1,968,284.34 |
| 4.56 | VEEV | VEEVA SYSTEMS INC-CLASS A | BFH3N85 | 280.08 | 6,944 | 1,944,875.52 |
| 4.55 | PODD | INSULET CORP | B1XGNW4 | 303.15 | 6,397 | 1,939,250.55 |
| 4.48 | PME AU | PRO MEDICUS LTD | 6292782 | 179.00 | 10,668 | 1,909,565.31 |
| 4.19 | TMDX | TRANSMEDICS GROUP INC | BK6TM04 | 123.56 | 14,465 | 1,787,295.40 |
| 4.07 | RMD | RESMED INC | 2732903 | 253.68 | 6,849 | 1,737,454.32 |
| 3.90 | GEHC | GE HEALTHCARE TECHNOLOGY | BL6JPG8 | 71.28 | 23,303 | 1,661,037.84 |
| 3.89 | IQV | IQVIA HOLDINGS INC | BDR73G1 | 154.73 | 10,716 | 1,658,086.68 |
| 3.83 | MASI | MASIMO CORP | B1YWR63 | 165.18 | 9,887 | 1,633,134.66 |
Exposure
As of May 31 2025| Sector | Weight (%) | |
|---|---|---|
| Health Care | 94.9 | |
| Materials | 2.7 | |
| Financials | 2.3 | |
| Other | 0.1 |
ETF Characteristics
As of Jun 20 2025| Return on Equity | 6.50% | |
| Weighted Avg. Market Cap | 18,780 M | |
| 2024 | 2025 | |
| Price-to-earnings | -534.50 | 76.36 |
| Price-to-book value | 5.19 | 4.73 |
ETF Risk Stats
As of May 31 2025| VERSUS | BETA |
|---|---|
| S&P 500 | 1.17 |
| NASDAQ-100 | 0.85 |
| MSCI EAFE | 0.96 |
| MSCI Emg. Mkts | 0.80 |
| Standard Deviation | 25.60% |
ETF Research
ETF Documents
Prospectus & Regulatory Information
* The financial statements include the Fund’s disclosures required by Items 7 through 11 of Form N-CSR, which includes the financial statements, financial highlights, and other important information when applicable.
** The financial statements include the Fund’s disclosures required by Items 7 through 11 of Form N-CSR, which includes the financial statements, financial highlights, and other important information when applicable.